Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (261-270 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Rheumatology|July 20, 2011
Immunology: Abdegs: an alternative to IVIg?David Killock
Nature Reviews. Rheumatology|September 7, 2011
Do autoantibodies to C3 exacerbate autoimmunity in SLE?David Killock
Nature Reviews. Clinical Oncology|October 12, 2016
Immunotherapy: Interferon in anti-CTLA-4 responsesDavid Killock
Nature Reviews. Clinical Oncology|October 1, 2014
Lung cancer: thoracic radiotherapy improves survival in small-cell lung cancerDavid Killock
Nature Reviews. Neurology|July 23, 2014
Multiple sclerosis: KIR4.1 as an autoantigen in MS--new questions raisedDavid Killock
Nature Reviews. Clinical Oncology|November 18, 2015
Can FCR be curative in CLL?David Killock
Nature Reviews. Clinical Oncology|August 5, 2015
Breast cancer: rational use of regional nodal irradiation neededDavid Killock
Nature Reviews. Clinical Oncology|January 21, 2016
CNS cancer: Breaking boundaries - IDH mutations in gliomaDavid Killock
Nature Reviews. Clinical Oncology|September 9, 2015
Immunotherapy: An attractive cell-therapy approachDavid Killock
Nature Reviews. Clinical Oncology|November 2, 2019
Benefits of adding ADT to RT confirmedDavid Killock
Pageof 31

Showing results (261-270 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Rheumatology|July 20, 2011
Immunology: Abdegs: an alternative to IVIg?David Killock
Nature Reviews. Rheumatology|September 7, 2011
Do autoantibodies to C3 exacerbate autoimmunity in SLE?David Killock
Nature Reviews. Clinical Oncology|October 12, 2016
Immunotherapy: Interferon in anti-CTLA-4 responsesDavid Killock
Nature Reviews. Clinical Oncology|October 1, 2014
Lung cancer: thoracic radiotherapy improves survival in small-cell lung cancerDavid Killock
Nature Reviews. Neurology|July 23, 2014
Multiple sclerosis: KIR4.1 as an autoantigen in MS--new questions raisedDavid Killock
Nature Reviews. Clinical Oncology|November 18, 2015
Can FCR be curative in CLL?David Killock
Nature Reviews. Clinical Oncology|August 5, 2015
Breast cancer: rational use of regional nodal irradiation neededDavid Killock
Nature Reviews. Clinical Oncology|January 21, 2016
CNS cancer: Breaking boundaries - IDH mutations in gliomaDavid Killock
Nature Reviews. Clinical Oncology|September 9, 2015
Immunotherapy: An attractive cell-therapy approachDavid Killock
Nature Reviews. Clinical Oncology|November 2, 2019
Benefits of adding ADT to RT confirmedDavid Killock
Pageof 31